Metformin Targets the Metabolic Achilles Heel of Human Pancreatic Cancer Stem Cells

PLoS ONE - Tập 8 Số 10 - Trang e76518
Enza Lonardo1, Michele Cioffi1, Patricia Sancho1, Yolanda Sanchez-Ripoll1, Sara Trabulo1, Jorge Navarro‐Dorado1, Anamaria Balic1, Manuel Hidalgo2, Christopher Heeschen1
1Stem Cells & Cancer Group, Molecular Pathology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
2Gastrointestinal Cancer Clinical Research Unit, Clinical Research Programme (CNIO), Spanish National Cancer Research Centre, Madrid, Spain

Tóm tắt

Từ khóa


Tài liệu tham khảo

A Jemal, 2010, Cancer statistics, 2010, CA Cancer J Clin, 60, 277, 10.3322/caac.20073

AB Lowenfels, 2006, Epidemiology and risk factors for pancreatic cancer, Best Pract Res Clin Gastroenterol, 20, 197, 10.1016/j.bpg.2005.10.001

D Li, 2012, Diabetes and pancreatic cancer, Mol Carcinog, 51, 64, 10.1002/mc.20771

E White, 2012, Deconvoluting the context-dependent role for autophagy in cancer, Nat Rev Cancer, 12, 401, 10.1038/nrc3262

JM Evans, 2005, Metformin and reduced risk of cancer in diabetic patients, BMJ, 330, 1304, 10.1136/bmj.38415.708634.F7

N Sadeghi, 2012, Metformin Use Is Associated with Better Survival of Diabetic Patients with Pancreatic Cancer, Clin Cancer Res

DS Michaud, 2004, Epidemiology of pancreatic cancer, Minerva Chir, 59, 99

RJ Shaw, 2005, The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin, Science, 310, 1642, 10.1126/science.1120781

F Meric-Bernstam, 2009, Targeting the mTOR signaling network for cancer therapy, J Clin Oncol, 27, 2278, 10.1200/JCO.2008.20.0766

MT Mueller, 2009, Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer, Gastroenterology, 137, 1102, 10.1053/j.gastro.2009.05.053

VN Anisimov, 2005, Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice, Exp Gerontol, 40, 685, 10.1016/j.exger.2005.07.007

B Martin-Castillo, 2010, Metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena, Cell Cycle, 9, 1057, 10.4161/cc.9.6.10994

K Kisfalvi, 2009, Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth, Cancer Res, 69, 6539, 10.1158/0008-5472.CAN-09-0418

B Bao, 2011, Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells, Cancer Prev Res (Phila), 5, 355, 10.1158/1940-6207.CAPR-11-0299

PC Hermann, 2007, Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer, Cell Stem Cell, 1, 313, 10.1016/j.stem.2007.06.002

D Jones, 2008, No place like home: anatomy and function of the stem cell niche, Nat Rev Mol Cell Biol, 9, 11, 10.1038/nrm2319

B Rubio-Viqueira, 2006, An in vivo platform for translational drug development in pancreatic cancer, Clin Cancer Res, 12, 4652, 10.1158/1078-0432.CCR-06-0113

E Lonardo, 2011, Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy, Cell Stem Cell, 10.1158/1538-7445.FBCR11-B45

N Ouslimani, 2005, Metformin decreases intracellular production of reactive oxygen species in aortic endothelial cells, Metabolism, 54, 829, 10.1016/j.metabol.2005.01.029

MG Vander Heiden, 2009, Understanding the Warburg effect: the metabolic requirements of cell proliferation, Science, 324, 1029, 10.1126/science.1160809

KP Olive, 2009, Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer, Science, 324, 1457, 10.1126/science.1171362

E Lonardo, 2012, Pancreatic stellate cells form a niche for cancer stem cells and promote their self-renewal and invasiveness, Cell Cycle, 11, 1282, 10.4161/cc.19679

I Garrido-Laguna, 2010, Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer, Br J Cancer, 103, 649, 10.1038/sj.bjc.6605819

G Hess, 2009, Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma, J Clin Oncol, 27, 3822, 10.1200/JCO.2008.20.7977

J Rehman, 2010, Empowering self-renewal and differentiation: the role of mitochondria in stem cells, J Mol Med (Berl), 88, 981, 10.1007/s00109-010-0678-2

MR Owen, 2000, Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain, Biochem J, 348 Pt 3, 607, 10.1042/bj3480607

HA Hirsch, 2009, Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission, Cancer Res, 69, 7507, 10.1158/0008-5472.CAN-09-2994

M Hidalgo, 2010, Pancreatic cancer, N Engl J Med, 362, 1605, 10.1056/NEJMra0901557

S Hamada, 2012, Pancreatic stellate cells enhance stem cell-like phenotypes in pancreatic cancer cells, Biochem Biophys Res Commun, 421, 349, 10.1016/j.bbrc.2012.04.014

A Jimeno, 2009, A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development, Mol Cancer Ther, 8, 310, 10.1158/1535-7163.MCT-08-0924

E Gallmeier, 2011, Inhibition of ATR Function Abrogates the in Vitro and in Vivo Tumorigenicity of Human Colon Cancer Cells Through Depletion of the CD133+ Tumor-Initiating Cell Fraction, Stem Cells, 29, 418, 10.1002/stem.595

E Lonardo, 2011, Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy, Cell Stem Cell, 9, 433, 10.1016/j.stem.2011.10.001